Chwalisz; Krzysztof

Patent Applications and Registrations

Patent applications and USPTO patent grants for Chwalisz; Krzysztof.The latest application filed is for "implantation rates after in vitro fertilization, and treatment of infertility and early pregnancy loss with a nitric oxide donor or substrate alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors in combination with antiprogestins or other agents".

Company Profile

0.12.1

Chwalisz; Krzysztof - Berlin DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Antiprogestin method for reducing side effects associated with low dosage HRT and oral contraception Grant 7,704,983 - Hodgen , et al. April 27, 2	2010-04-27
Treatment of preeclampsia, toxemia and preterm labor with combination of progestational agent and a nitric oxide synthase substrate and/or donor Grant 6,844,320 - Garfield , et al. January 18, 2	2005-01-18
Implantation rates after in vitro fertilization, and treatment of infertility and early pregnancy loss with a nitric oxide donor or substrate alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors in combination with antiprogestins or other agents App 20020169205 - Chwalisz, Krzysztof ; et al.	2002-11-14
Methods of and apparatus for activating the muscle cells or nerves of the uterus or cervix Grant 6,356,777 - Garfield , et al. March 12, 2	2002-03-12
Implantation rates after in vitro fertilization, treatment of infertility and early pregnancy loss with a nitric oxide donor alone or in combination with progesterone, and a method for contraception with nitric oxide inhibitors Grant 6,040,340 - Chwalisz , et al. March 21, 2	2000-03-21
Methods for activating the muscle cells or nerves of the uterus or cervix Grant 5,991,649 - Garfield , et al. November 23, 1	1999-11-23
6,7-modified 11.beta.-aryl-4-oestrenes Grant 5,843,931 - Ottow , et al. December 1, 1	1998-12-01
Treatment of climacteric disorders with nitric oxide synthase substrates and/or donors Grant 5,595,970 - Garfield , et al. January 21, 1	1997-01-21
Methods for measuring uterine electrical and mechanical activity Grant 5,522,877 - Garfield , et al. June 4, 1	1996-06-04
Methods of and apparatus for measuring uterine electrical and mechanical activity Grant 5,397,344 - Garfield , et al. March 14, 1	1995-03-14
13-alkyl-11.beta.-phenylgonanes Grant 5,273,971 - Scholz , et al. December 28, 1	1993-12-28
11.beta.-phenyl-4,9,15-estratrienes, their manufacture and pharmaceutical preparations containing same Grant 5,132,299 - Ottow , et al. July 21, 1	1992-07-21
Coadministration of antigestagen and antiestrogen for gynecological disorders, abortion and labor induction Grant 4,888,331 - Elger , et al. December 19, 1	1989-12-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.